Open original FDA record ↗Recall record
- FDA identifier
- Z-1084-2026
- Company in FDA record
- Diagnostica Stago, Inc.
- FDA classification date
- Jan 14, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for defect for Asserachrom HPIA lot 271288, which can affect every well in the impacted strip and produce negative results.
Source facts
- Action
- Diagnostica Stago notified consignees of the recall on about 12/15/2025 via email. Consignees were instructed to stop using Lot 271288 and dispose of all remaining product according to local regulations, and complete, sign, and return the attached Acknowledgement Form provided. Additionally, consignees were instructed that if they have distributed the affected lot to any other laboratory, please notify those recipients of this recall and ask them to complete and return an Acknowledgement Form.
- Initiated
- 2025-12-15
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide distribution in the states of AL, CA, FL, GA, HI, IA, MA, MI, NJ, NV, NY, OH, TN, WI and the countries of Belgium, Canada, Denmark, Algeria, Spain, Finland, France, Great Britain, Italy, Lebanon, Saudi Arabia, Uganda.
- Recall number
- Z-1084-2026
- Recall status
- Open, Classified
- CDRH record ID
- 217753
- FDA classified
- 2026-01-14
- Recall event number
- 98163